ASPCF News and Press, Acerus Pharmaceuticals Corp From 03/11/21

Acerus Pharmaceuticals Corporation (ASPCF) Q4 2020 Earnings Conference Call March 11, 2021 10:00 ET Company Participants Bob Motz - Chief Financial Officer Ed Gudaitis - President & Chief Executive Officer Conference Call Participants Presentation Operator Good morning, ladies and gentlem...

Acerus Pharmaceuticals (ASPCF): Q4 GAAP EPS of -$0.01.Revenue of $0.3M (-40.0% Y/Y)Press Release For further details see: Acerus Pharmaceuticals reports Q4 results

TORONTO, March 11, 2021 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (“Acerus” or the “Company”) (TSX: ASP; OTCQB: ASPCF) today reported its financial results for the three and twelve-month period ended December 31, 2020. Unless otherwise noted, all amo...

TORONTO, March 04, 2021 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (TSX:ASP; OTCQB:ASPCF) will announce its fourth quarter and full year 2020 financial and operating results on Thursday, March 11, 2021 before the market opens. The company will host a conference call on Thursday,...

Acerus Pharmaceuticals Corporation (“Acerus” or the “Company”) (TSX: ASP, OTCQB: ASPCF) today announced that it received a waiver letter from SWK Funding LLC (“SWK”) related to the required Minimum Revenue Covenant for Q4-2020 in its existing cr...

Acerus Pharmaceuticals Corporation (“ Acerus ” or the “ Company ”) (TSX: ASP, OTCQB: ASPCF) is pleased to announce that, further to its press release dated November 25, 2020 with respect to the completion of Acerus’ rights offering (the &#x...

Acerus Pharmaceuticals Corporation (“ Acerus ” or the “ Company ”) (TSX: ASP, OTCQB: ASPCF) is pleased to announce the completion of its rights offering (the “ Rights Offering ”), which expired at 5:00 pm (EST) on November 24, 20...

Acerus Pharmaceuticals Corporation (ASPCF) Q3 2020 Results Earnings Conference Call November 03, 2020, 10:00 AM ET Company Participants Bob Motz - CFO Ed Gudaitis - President and CEO Gavin Damstra - Senior Vice President, US Commercial Chris Sorli - Chief Medical Officer Gavin Damstra - Senio...

TORONTO - Acerus Pharmaceuticals Corporation (“Acerus” or the “Company”) (TSX:ASP; OTCQB:ASPCF) today reported its financial results for the three and nine-month period ended September 30, 2020. Unless otherwise noted, all amounts are in US dollars and are pr...

Acerus Pharmaceuticals Corporation (TSX:ASP; OTCQB:ASPCF) will announce its third quarter 2020 financial and operating results on Tuesday, November 3, 2020 before the market opens. The company will host a conference call on Tuesday, November 3, 2020 at 10:00 a.m. Eastern Time. To ac...